instruction
stringlengths 4
15.8k
| input
stringclasses 1
value | output
stringlengths 1
5.09k
| text
stringlengths 152
16.1k
|
---|---|---|---|
How did heparin doses compare to aPTT values?
|
lower doses
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How did heparin doses compare to aPTT values?. ### Response: lower doses.
|
|
What are the limits of heparin in addition to hemor-rhagic complications?
|
pharmacokinetic properties
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are the limits of heparin in addition to hemor-rhagic complications?. ### Response: pharmacokinetic properties.
|
|
What is the ability to do with anti-Xa levels in patients with VTE?
|
adjust heparin doses
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the ability to do with anti-Xa levels in patients with VTE?. ### Response: adjust heparin doses.
|
|
What can lead to osteoporosis?
|
bone metabolism
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What can lead to osteoporosis?. ### Response: bone metabolism.
|
|
What are some nonhemorrhagic side effects?
|
skin reactions that can progress to necrosis, alopecia, and hypersen-sitivity reactions
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are some nonhemorrhagic side effects?. ### Response: skin reactions that can progress to necrosis, alopecia, and hypersen-sitivity reactions.
|
|
Skin reactions that can progress to necrosis are examples of what?
|
nonhemorrhagic side effects
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Skin reactions that can progress to necrosis are examples of what?. ### Response: nonhemorrhagic side effects.
|
|
What are skin reactions that can progress to necrosis, alopecia, and hypersen-sitivity reactions?
|
nonhemorrhagic side effects
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are skin reactions that can progress to necrosis, alopecia, and hypersen-sitivity reactions?. ### Response: nonhemorrhagic side effects.
|
|
What are hypersensitivity reactions to heparin?
|
uncommon
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are hypersensitivity reactions to heparin?. ### Response: uncommon.
|
|
In 2007, an unusually high number of adverse events with what drug were reported in North America?
|
heparin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: In 2007, an unusually high number of adverse events with what drug were reported in North America?. ### Response: heparin.
|
|
What was the cause of these reactions?
|
Aprotinin and nitroglycerin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the cause of these reactions?. ### Response: Aprotinin and nitroglycerin.
|
|
Where was the contaminant in heparin manufac-tured?
|
China
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Where was the contaminant in heparin manufac-tured?. ### Response: China.
|
|
What was the contaminant in heparin manufac-tured in China?
|
chondroitin sulfate
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the contaminant in heparin manufac-tured in China?. ### Response: chondroitin sulfate.
|
|
What is postulated that when given in therapeutic doses, the anticoagulant can be what?
|
94
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is postulated that when given in therapeutic doses, the anticoagulant can be what?. ### Response: 94.
|
|
Asians vs non-Asians were compared for what?
|
standard-dose NOACs
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Asians vs non-Asians were compared for what?. ### Response: standard-dose NOACs.
|
|
What were the effect sizes of the primary ef ficacy end point (stroke and systemicembolism) and the primary safety end point?
|
greater
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What were the effect sizes of the primary ef ficacy end point (stroke and systemicembolism) and the primary safety end point?. ### Response: greater.
|
|
What was the risk reduction in hemorrhagic stroke and gastrointestinalbleeding greater in Asians vs non-Asians?
|
standard-dose NOACs
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the risk reduction in hemorrhagic stroke and gastrointestinalbleeding greater in Asians vs non-Asians?. ### Response: standard-dose NOACs.
|
|
What was more effective and safer for Asians when compared with warfarin?
|
standard-dose NOACs
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was more effective and safer for Asians when compared with warfarin?. ### Response: standard-dose NOACs.
|
|
How many mg of rivaroxaban were used for low-dose NOACs?
|
20 mg
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many mg of rivaroxaban were used for low-dose NOACs?. ### Response: 20 mg.
|
|
What are three low-dose NOACs?
|
dabigatran 110 mg, rivaroxaban15 mg, and edoxaban 30 mg
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are three low-dose NOACs?. ### Response: dabigatran 110 mg, rivaroxaban15 mg, and edoxaban 30 mg.
|
|
What is rivaroxaban 15 mg/10 mg?
|
low-dose NOACs
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is rivaroxaban 15 mg/10 mg?. ### Response: low-dose NOACs.
|
|
What is more commonly used than standard-dose NOACs?
|
warfarin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is more commonly used than standard-dose NOACs?. ### Response: warfarin.
|
|
What was associated with reduced risk of ischemic stroke or systemicembolization, major bleeding, ICH, and total mortality compared with warfarin?
|
the use of NOACs
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was associated with reduced risk of ischemic stroke or systemicembolization, major bleeding, ICH, and total mortality compared with warfarin?. ### Response: the use of NOACs.
|
|
Published data suggest thatNOACs are preferentially indicated for stroke prevention in what ethnicity?
|
Asians
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Published data suggest thatNOACs are preferentially indicated for stroke prevention in what ethnicity?. ### Response: Asians.
|
|
What are NOACs better than than VKAs?
|
serious bleeding
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are NOACs better than than VKAs?. ### Response: serious bleeding.
|
|
What discourages initiation of anticoagulant therapy in patients at highrisk of bleeding?
|
Thepotential for bleeding
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What discourages initiation of anticoagulant therapy in patients at highrisk of bleeding?. ### Response: Thepotential for bleeding.
|
|
Patients who experience a bleed frequently have permanent or prolonged discontinuation of what?
|
their anticoagulant
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Patients who experience a bleed frequently have permanent or prolonged discontinuation of what?. ### Response: their anticoagulant.
|
|
What is a safer anticoagulant than thrombin and factor Xa inhibitors?
|
warfarin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a safer anticoagulant than thrombin and factor Xa inhibitors?. ### Response: warfarin.
|
|
What are the upstreamtargets for factor xI and factorxII in the contact pathway?
|
factor XI and factor XII
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are the upstreamtargets for factor xI and factorxII in the contact pathway?. ### Response: factor XI and factor XII.
|
|
What is thrombosis with minimal or no role inhemostasis?
|
factor XI and factor XII
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is thrombosis with minimal or no role inhemostasis?. ### Response: factor XI and factor XII.
|
|
What are strategies to target factor XII or factorXI?
|
antisense oligonucleotides that reduce hepaticsynthesis of the clotting proteins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are strategies to target factor XII or factorXI?. ### Response: antisense oligonucleotides that reduce hepaticsynthesis of the clotting proteins.
|
|
Antisense oligonucleotides that reduce hepaticsynthesis of the clotting proteins are what?
|
polyanion antagonists
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Antisense oligonucleotides that reduce hepaticsynthesis of the clotting proteins are what?. ### Response: polyanion antagonists.
|
|
What are polyanion antagonists that attenuate contact activation by nullifying stimulators of the pathway?
|
clotting proteins, monoclonal antibodiesthat block activation or activity, aptamers, small moleculesthat block the active site or induce allosteric modulation,and polyanion antagonists that attenuate contact activationby nullifying stimulators of the pathway.7
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are polyanion antagonists that attenuate contact activation by nullifying stimulators of the pathway?. ### Response: clotting proteins, monoclonal antibodiesthat block activation or activity, aptamers, small moleculesthat block the active site or induce allosteric modulation,and polyanion antagonists that attenuate contact activationby nullifying stimulators of the pathway.7.
|
|
What was compared with enoxaparin in 300 patientsundergoing elective knee arthroplasty?
|
IONIS-416858
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was compared with enoxaparin in 300 patientsundergoing elective knee arthroplasty?. ### Response: IONIS-416858.
|
|
How many days prior to surgery was enoxaparin given at adose of 40 mg?
|
35
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many days prior to surgery was enoxaparin given at adose of 40 mg?. ### Response: 35.
|
|
How many mgIONIS-416858 regimen was noninferior?
|
200
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many mgIONIS-416858 regimen was noninferior?. ### Response: 200.
|
|
What regimen was superior in preventing the end point of asymptomatic DVT, pulmonary embolism, or VTE-related mortality?
|
IONIS-416858
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What regimen was superior in preventing the end point of asymptomatic DVT, pulmonary embolism, or VTE-related mortality?. ### Response: IONIS-416858.
|
|
What is another term for VTE-related mortality?
|
pulmonary embolism
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is another term for VTE-related mortality?. ### Response: pulmonary embolism.
|
|
What was the rate of major or clinically relevant nonmajor bleeding in both IONIS-treated patients?
|
3%
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the rate of major or clinically relevant nonmajor bleeding in both IONIS-treated patients?. ### Response: 3%.
|
|
What does early rivaroxaban use after cardioembolic stroke not result in?
|
hemorrhagic trans-formation
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does early rivaroxaban use after cardioembolic stroke not result in?. ### Response: hemorrhagic trans-formation.
|
|
What is the name of the prospective magnetic resonance imaging study that may not cause hemorrhagic transformation?
|
Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, Bussiere M, Jeerakathil T, Shuaib A, Emery D, et al. Early rivaroxaban
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the prospective magnetic resonance imaging study that may not cause hemorrhagic transformation?. ### Response: Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, Bussiere M, Jeerakathil T, Shuaib A, Emery D, et al. Early rivaroxaban.
|
|
What is the name of the study that investigated resonance imaging?
|
STROKEAHA
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the study that investigated resonance imaging?. ### Response: STROKEAHA.
|
|
When was Stroke.47:1917-1919?
|
2016
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When was Stroke.47:1917-1919?. ### Response: 2016.
|
|
What is one of the main findings of the resonance imaging study?
|
Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic trans-formation
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is one of the main findings of the resonance imaging study?. ### Response: Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic trans-formation.
|
|
What is more effective than heparin?
|
aspirin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is more effective than heparin?. ### Response: aspirin.
|
|
What is the name of the meta-analysis of ischaemic stroke?
|
individual patient data meta-analysis of randomised controlled trials
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the meta-analysis of ischaemic stroke?. ### Response: individual patient data meta-analysis of randomised controlled trials.
|
|
What is more effective than aspirin in preventing early neurologic deteri-oration?
|
Low-molecular-weight heparin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is more effective than aspirin in preventing early neurologic deteri-oration?. ### Response: Low-molecular-weight heparin.
|
|
What is the effect of low-molecular-weight heparin on neurologic outcome?
|
improving six-month outcome
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the effect of low-molecular-weight heparin on neurologic outcome?. ### Response: improving six-month outcome.
|
|
In what year did J Stroke Cerebrovasc Dis.23:1537β1544 appear?
|
2014
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: In what year did J Stroke Cerebrovasc Dis.23:1537β1544 appear?. ### Response: 2014.
|
|
What is ALIAS?
|
Albumin in Acute Ischemic Stroke
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is ALIAS?. ### Response: Albumin in Acute Ischemic Stroke.
|
|
What is the name of the double-blind, placebo-controlled trial of high-dose al-bumin?
|
part 2
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the double-blind, placebo-controlled trial of high-dose al-bumin?. ### Response: part 2.
|
|
What is the name of the double-blind, placebo-controlled trial?
|
Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the double-blind, placebo-controlled trial?. ### Response: Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial.
|
|
When did the Lancet Neurol. 2013 issue 12:1049-1058?
|
2013
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When did the Lancet Neurol. 2013 issue 12:1049-1058?. ### Response: 2013.
|
|
What are the parts 1 and 2 of ALIAS?
|
NETT Investigators
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are the parts 1 and 2 of ALIAS?. ### Response: NETT Investigators.
|
|
What are the parts 1 and 2 of the Stroke trials?
|
ALIAS Parts 1 and 2 and NETT Investigators. ALIAS (Albumin in Acute Ischemic Stroke) trials
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are the parts 1 and 2 of the Stroke trials?. ### Response: ALIAS Parts 1 and 2 and NETT Investigators. ALIAS (Albumin in Acute Ischemic Stroke) trials.
|
|
What is the name of the study that investigated the safety of using external counterpulsation to augment cardiac output?
|
Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the study that investigated the safety of using external counterpulsation to augment cardiac output?. ### Response: Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial.
|
|
What does CUFFS stand for?
|
Counterpulsation to Upgrade Forward Flow in Stroke
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does CUFFS stand for?. ### Response: Counterpulsation to Upgrade Forward Flow in Stroke.
|
|
What is the name of the trial to augment cerebral blood flow in stroke?
|
Neurological Emergencies Treatment Trials
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the trial to augment cerebral blood flow in stroke?. ### Response: Neurological Emergencies Treatment Trials.
|
|
When was the Counterpulsation to Upgrade Forward Flow in Stroke Trial?
|
2015
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When was the Counterpulsation to Upgrade Forward Flow in Stroke Trial?. ### Response: 2015.
|
|
What is prehospital use of magnesium sulfate as neuroprotection in acute stroke?
|
FAST-MAG Investigators and Coordinators
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is prehospital use of magnesium sulfate as neuroprotection in acute stroke?. ### Response: FAST-MAG Investigators and Coordinators.
|
|
What is the doi: 10.1056/NEJMoa1408827 236?
|
N Engl J Med.
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the doi: 10.1056/NEJMoa1408827 236?. ### Response: N Engl J Med..
|
|
How does transcranial near-infrared laser therapy treat stroke patients?
|
light approach
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How does transcranial near-infrared laser therapy treat stroke patients?. ### Response: light approach.
|
|
What is a translational science?
|
transcranial near-infrared laser therapy
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a translational science?. ### Response: transcranial near-infrared laser therapy.
|
|
When was the last time a patient had a stroke?
|
1049β10
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When was the last time a patient had a stroke?. ### Response: 1049β10.
|
|
What is the address of the International Society of Nephrology?
|
Global Operations Center, Avenue des Arts1-2, B-1210 Brussels, Belgium
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the address of the International Society of Nephrology?. ### Response: Global Operations Center, Avenue des Arts1-2, B-1210 Brussels, Belgium.
|
|
Where is the Global Operations Center located?
|
Brussels, Belgium
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Where is the Global Operations Center located?. ### Response: Brussels, Belgium.
|
|
What should be addressed to: USA/Canada:Jane Liss, Tel: +1 732-890-9812, E-mail: [email protected] and JenCallow, Tel?
|
AdvertisingInquiries concerning display advertising
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What should be addressed to: USA/Canada:Jane Liss, Tel: +1 732-890-9812, E-mail: [email protected] and JenCallow, Tel?. ### Response: AdvertisingInquiries concerning display advertising.
|
|
Who is responsible for recruiting/classi fied advertising?
|
Rob Issler
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who is responsible for recruiting/classi fied advertising?. ### Response: Rob Issler.
|
|
What is Rob Issler's email address?
|
+1 321
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is Rob Issler's email address?. ### Response: +1 321.
|
|
Who should inquire about Kidney International Supplements?
|
Craig Smith
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who should inquire about Kidney International Supplements?. ### Response: Craig Smith.
|
|
What does the International Society of Nephrology own?
|
copyright
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does the International Society of Nephrology own?. ### Response: copyright.
|
|
What is the name of the organization that owns the journal?
|
International Society of Nephrology
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the organization that owns the journal?. ### Response: International Society of Nephrology.
|
|
Who is responsible for the use of the journal and contributions?
|
International Society of Nephrology
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who is responsible for the use of the journal and contributions?. ### Response: International Society of Nephrology.
|
|
What is not required for photocopying of articlespublished under the CC BY license?
|
Permission
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is not required for photocopying of articlespublished under the CC BY license?. ### Response: Permission.
|
|
What may single photocopies of single articles be made for?
|
personal use
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What may single photocopies of single articles be made for?. ### Response: personal use.
|
|
What is required for all othercopying?
|
Permission of the publisher and payment of a fee
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is required for all othercopying?. ### Response: Permission of the publisher and payment of a fee.
|
|
What is a noncommercial license?
|
CC BY-NC-ND
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a noncommercial license?. ### Response: CC BY-NC-ND.
|
|
What is the purpose of copying for?
|
advertisingor promotional purposes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the purpose of copying for?. ### Response: advertisingor promotional purposes.
|
|
What are special rates available for educational institutions that wish to make photocopies for classroom use?
|
Special ratesare available for educational institutions that wish to make photocopies fornonpro ο¬
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are special rates available for educational institutions that wish to make photocopies for classroom use?. ### Response: Special ratesare available for educational institutions that wish to make photocopies fornonpro ο¬.
|
|
What is required for all articles published under a CC BY-NC-ND license?
|
permission of the publisher
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is required for all articles published under a CC BY-NC-ND license?. ### Response: permission of the publisher.
|
|
What is not required for resale or distribution outside the subscribing institution or company?
|
Permission
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is not required for resale or distribution outside the subscribing institution or company?. ### Response: Permission.
|
|
What type of license is required for all other derivative works?
|
CC BY-NC-ND
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What type of license is required for all other derivative works?. ### Response: CC BY-NC-ND.
|
|
What is required of all derivative works, includingcompilations and translations?
|
permission of the publisher
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is required of all derivative works, includingcompilations and translations?. ### Response: permission of the publisher.
|
|
What does absence of RCT data preclude at this time?
|
guideline recommenda-tions
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does absence of RCT data preclude at this time?. ### Response: guideline recommenda-tions.
|
|
When was this document downloaded?
|
April 28, 2023
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When was this document downloaded?. ### Response: April 28, 2023.
|
|
What is the effect of metformin on cardiovascu-lar disease among people with type 2 diabetes?
|
a meta-analysis of randomised trials
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the effect of metformin on cardiovascu-lar disease among people with type 2 diabetes?. ### Response: a meta-analysis of randomised trials.
|
|
What are the results of empagliflozin and cardiovascular outcomes?
|
mortality
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are the results of empagliflozin and cardiovascular outcomes?. ### Response: mortality.
|
|
What type of diabetes is canagliflozin associated with?
|
type 2 diabetes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What type of diabetes is canagliflozin associated with?. ### Response: type 2 diabetes.
|
|
What year did N Engl J Med issue 377:644-57?
|
2017
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What year did N Engl J Med issue 377:644-57?. ### Response: 2017.
|
|
What is the name of the drug that has been linked to cardiovascular outcomes in type 2 diabetes?
|
Liraglutide
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the drug that has been linked to cardiovascular outcomes in type 2 diabetes?. ### Response: Liraglutide.
|
|
What was the N Engl J Med. 2016:375:311β22?
|
Liraglutide and cardiovascular outcomes in type 2 diabetes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the N Engl J Med. 2016:375:311β22?. ### Response: Liraglutide and cardiovascular outcomes in type 2 diabetes.
|
|
Who is the author of Dapagliflozin and cardiovascular outcomes?
|
Wiviott
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who is the author of Dapagliflozin and cardiovascular outcomes?. ### Response: Wiviott.
|
|
What is the name of the double-blind, randomised placebo-controlled trial?
|
Lancet
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the double-blind, randomised placebo-controlled trial?. ### Response: Lancet.
|
|
What is another name for Harmony Outcomes?
|
cardio-vascular disease
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is another name for Harmony Outcomes?. ### Response: cardio-vascular disease.
|
|
What is the name of the drug used to treat type 2 diabetes?
|
Albiglutide
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the drug used to treat type 2 diabetes?. ### Response: Albiglutide.
|
|
When was the N Engl J Med 375:1834-44 published?
|
2016
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: When was the N Engl J Med 375:1834-44 published?. ### Response: 2016.
|
|
What year did the American Heart Association publish a report on heart disease and stroke statistics?
|
2018
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What year did the American Heart Association publish a report on heart disease and stroke statistics?. ### Response: 2018.
|
|
What type of diabetes is multifactorial intervention and car-diovascular disease in?
|
type 2
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What type of diabetes is multifactorial intervention and car-diovascular disease in?. ### Response: type 2.
|
|
What year did N Engl J Med. 2003:348:383-93?
|
2016
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What year did N Engl J Med. 2003:348:383-93?. ### Response: 2016.
|
|
How did Gaede P, Vedel P, Larsen N, et al. study the effect of lifestyle on incident cardiovascular disease and mortality in patients with diabetes?
|
Multifactorial intervention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How did Gaede P, Vedel P, Larsen N, et al. study the effect of lifestyle on incident cardiovascular disease and mortality in patients with diabetes?. ### Response: Multifactorial intervention.
|
|
What is the effect of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus?
|
Influence
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the effect of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus?. ### Response: Influence.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.